Rx Firms Keeping A Close Eye On Lagging OTC Market Growth
This article was originally published in The Tan Sheet
Executive Summary
Roche's decision to shop its OTC unit is an example of a pharmaceutical company putting increased profit margins ahead of long-term steady cash flow